Putting typhoid vaccination on the global health agenda

New England Journal of Medicine

Volumn 357, Issue 11, 2007, Pages 1069-1071

  DeRoeck, Denise ^a   Jodar, Luis ^a   Clemens, John ^a  

^a International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; INACTIVATED VACCINE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TYPHOID VACCINE; TYPHOID PARATYPHOID VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CAUSE OF DEATH; DEVELOPING COUNTRY; DRUG COST; ENDEMIC DISEASE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; MORTALITY; PRIORITY JOURNAL; SALMONELLA TYPHI; SHORT SURVEY; SINGLE DRUG DOSE; TYPHOID FEVER; UNSPECIFIED SIDE EFFECT; VACCINATION; WORLD HEALTH ORGANIZATION; ARTICLE; DRUG EFFECT; HEALTH; PREVENTIVE HEALTH SERVICE;

DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNIZATION PROGRAMS; SALMONELLA TYPHI; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; WORLD HEALTH;

EID: 34548722672     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp078144     Document Type: Article

References (5)

1. Initiative for Vaccine Research. Typhoid fever. (Accessed August 23, 2007, at http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index7.html. )
2. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004;82:346-53.
3. GAVI Alliance home page. (Accessed August 23, 2007, at http://www.gavialliance.org.)
4. Acosta CJ, Galindo CM, Deen JL, et al. Vaccines against cholera, typhoid fever and shigellosis for developing countries. Expert Opin Biol Ther 2004;4:1939-51.
5. Ochiai RL, Wang X, von Seidlein L, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 2005;11:1764-6.